Percheron Therapeutics (PERCF) Q1 2025 Earnings

19FebConfirmed
Q3 2024
Q1 2025
-0.01
-0.01
-0.01
-0

Details

Expected EPS
-0.00928005
Actual EPS
-0.005691764
Surprise EPS
0
Surprise Percent
+38.67%

Description

Percheron Therapeutics (PERCF) has reported earnings of -0.005691764 per share for Q1 2025.

0 Comments

Share your thoughts